ENG
Endoglin
Also known as: CD105, EGLN_HUMAN, END, HHT1, ORW, ORW1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P17813
- Gene
- ENG
- Ensembl
- ENSG00000106991
- Chromosome
- 9
- Canonical length
- 658 aa
- Protein class
- Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a homodimeric transmembrane protein which is a major glycoprotein of the vascular endothelium. This protein is a component of the transforming growth factor beta receptor complex and it binds to the beta1 and beta3 peptides with high affinity. Mutations in this gene cause hereditary hemorrhagic telangiectasia, also known as Osler-Rendu-Weber syndrome 1, an autosomal dominant multisystemic vascular dysplasia. This gene may also be involved in preeclampsia and several types of cancer. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2013]
Canonical amino-acid sequenceUniProt
658 residues, UniProt reviewed canonical sequence.
>P17813|ENG
1 MDRGTLPLAV ALLLASCSLS PTSLAETVHC DLQPVGPERG EVTYTTSQVS KGCVAQAPNA
61 ILEVHVLFLE FPTGPSQLEL TLQASKQNGT WPREVLLVLS VNSSVFLHLQ ALGIPLHLAY
121 NSSLVTFQEP PGVNTTELPS FPKTQILEWA AERGPITSAA ELNDPQSILL RLGQAQGSLS
181 FCMLEASQDM GRTLEWRPRT PALVRGCHLE GVAGHKEAHI LRVLPGHSAG PRTVTVKVEL
241 SCAPGDLDAV LILQGPPYVS WLIDANHNMQ IWTTGEYSFK IFPEKNIRGF KLPDTPQGLL
301 GEARMLNASI VASFVELPLA SIVSLHASSC GGRLQTSPAP IQTTPPKDTC SPELLMSLIQ
361 TKCADDAMTL VLKKELVAHL KCTITGLTFW DPSCEAEDRG DKFVLRSAYS SCGMQVSASM
421 ISNEAVVNIL SSSSPQRKKV HCLNMDSLSF QLGLYLSPHF LQASNTIEPG QQSFVQVRVS
481 PSVSEFLLQL DSCHLDLGPE GGTVELIQGR AAKGNCVSLL SPSPEGDPRF SFLLHFYTVP
541 IPKTGTLSCT VALRPKTGSQ DQEVHRTVFM RLNIISPDLS GCTSKGLVLP AVLGITFGAF
601 LIGALLTAAL WYIYSHTRSP SKREPVVAVA APASSESSST NHSIGSTQST PCSTSSMALocalizationUniProt · AlphaFold · HPA
Whether an antibody against ENG can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 519 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 519 nTPM
- blood vessel: 349 nTPM
- lung: 251 nTPM
- adipose tissue: 224 nTPM
- spleen: 219 nTPM
- ovary: 214 nTPM
Single-cell type
- peritubular myoid cells: 1,904 nCPM
- leydig cells: 765 nCPM
- syncytiotrophoblasts: 674 nCPM
- vascular endothelial cells: 643 nCPM
- extravillous trophoblasts: 495 nCPM
- hepatic stellate cells: 265 nCPM
Immune cell
- intermediate monocyte: 28 nTPM
- non-classical monocyte: 22 nTPM
- classical monocyte: 20 nTPM
- myeloid DC: 10 nTPM
- total PBMC: 8.4 nTPM
- NK-cell: 7.6 nTPM
Brain region
- thalamus: 90 nTPM
- pons: 73 nTPM
- choroid plexus: 68 nTPM
- medulla oblongata: 63 nTPM
- midbrain: 60 nTPM
- cerebellum: 56 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ENG.
Disease | AllUniProt
Conditions ENG is implicated in, by any mechanism.
- Telangiectasia, hereditary hemorrhagic, 1 (HHT1) MIM:187300
Disease | GeneticClinVar
629 pathogenic / likely-pathogenic of 1,989 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hereditary hemorrhagic telangiectasia
- Cardiovascular phenotype
- Telangiectasia, hereditary hemorrhagic, type 1
- ENG-related disorder
- See cases
ReferencesPubMed · IEDB
Publications for ENG from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
5 publications
- Diagnostic role of endothelial microparticles in vasculitis.
2008 · Rheumatology (Oxford) · RCR 2.4 · 90 citations - Active immunotherapy of tumors with a recombinant xenogeneic endoglin as a model antigen.
2004 · Eur J Immunol · RCR 0.7 · 39 citations - Evaluation of angiogenesis in 77 pituitary adenomas using endoglin as a marker.
2009 · Neuropathology · RCR 0.5 · 18 citations - A plasmid DNA vaccine encoding the extracellular domain of porcine endoglin induces anti-tumour immune response against self-endoglin-related angiogenesis in two liver cancer models.
2006 · Dig Liver Dis · RCR 0.3 · 13 citations - [A DNA vaccine encoding the extracellular domain of porcine endoglin induces antitumor immunity in a mouse colon carcinoma model].
2005 · Ai Zheng
Reference: T cellIEDB
1 publication
- Identification and Validation of Th1-Selective Epitopes Derived from Proteins Overexpressed in Breast Cancer Stem Cells.
2025 · Vaccines (Basel) · 2 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.24
- gnomAD pLI
- 1
- gnomAD missense Z
- 0.93
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- artery morphogenesis
- atrial cardiac muscle tissue morphogenesis
- atrioventricular canal morphogenesis
- BMP signaling pathway
- branching involved in blood vessel morphogenesis
- cardiac atrium morphogenesis
- cardiac ventricle morphogenesis
- cell adhesion
- cell chemotaxis
- cell migration
- cell migration involved in endocardial cushion formation
- cell motility
- central nervous system vasculogenesis
- detection of hypoxia
- dorsal aorta morphogenesis
- endocardial cushion morphogenesis
- epithelial to mesenchymal transition involved in endocardial cushion formation
- extracellular matrix disassembly
- heart looping
- negative regulation of cell migration
- negative regulation of endothelial cell proliferation
- negative regulation of gene expression
- negative regulation of SMAD protein signal transduction
- negative regulation of transcription by RNA polymerase II
- negative regulation of transforming growth factor beta receptor signaling pathway
- outflow tract septum morphogenesis
- positive regulation of angiogenesis
- positive regulation of BMP signaling pathway
- positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- positive regulation of SMAD protein signal transduction
- positive regulation of systemic arterial blood pressure
- positive regulation of transcription by RNA polymerase II
- positive regulation of vascular associated smooth muscle cell differentiation
- regulation of cell adhesion
- regulation of cell population proliferation
- regulation of DNA-templated transcription
- regulation of transforming growth factor beta receptor signaling pathway
- response to hypoxia
- smooth muscle tissue development
- transforming growth factor beta receptor signaling pathway
- vascular associated smooth muscle cell development
- vasculogenesis
- venous blood vessel morphogenesis
- ventricular trabecula myocardium morphogenesis
- wound healing
Molecular functions
- activin binding
- coreceptor activity
- galactose binding
- glycosaminoglycan binding
- identical protein binding
- protein homodimerization activity
- signaling receptor activator activity
- transforming growth factor beta binding
- transmembrane signaling receptor activity
- type I transforming growth factor beta receptor binding
- type II transforming growth factor beta receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ENG in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ENG as an antibody target. Whether an autoantibody or antibody against ENG could matter depends on whether native ENG is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ENG is annotated at the cell surface, where native ENG is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ENG as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...